(PHGE) – FDA
-
BiomX Inc. (PHGE) Reports Positive Results from Part 1 of the Phase 1b/2a Study of BX004
-
BiomX Inc. (PHGE) and Boehringer Ingelheim Collaborate Over Inflammatory Bowel Disease Microbiome Biomarkers
-
-
-
-
-
-
-
-
-
Back to PHGE Stock Lookup